Hospitalist Doctors in Athens, OH Accepting Medicare

4 Hospitalist doctors found. Showing 1 - 4

Jacob William Snyder, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Hospital Dr, Athens, OH 45701 Phone: 740-593-5991

Amber Gokkaya, FNP-C Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Hospital Dr, Athens, OH 45701 Phone: 740-593-5551    Fax: 740-566-4625

Dr. Gavin Paul Baumgardner, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Hospital Dr, Suite 1545, Athens, OH 45701 Phone: 740-593-5551    Fax: 614-923-7813

Edward Scott Umlauf, D.O. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 55 Hospital Dr, Athens, OH 45701 Phone: 740-593-5551

News Archive

Uric acid holds potential for central nervous system damage

Uric acid is commonly associated with the excruciatingly painful joint disease known as gout, but it can also play a crucial role in the treatment of spinal cord injury and other central nervous system disorders, such as stroke, multiple sclerosis and Parkinson's disease, according to Rutgers' Bonnie Firestein.

Southridge, Curaxis Pharmaceutical announce $25 million equity purchase agreement

Stephen Hicks, Chairman and CEO, of Southridge LLC and Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp , jointly announced a $25 million equity purchase agreement with Southridge Partners II, an institutional investor.

Limerick to announce new results from LIM-0705 human trials at 23rd Transplantation Society congress

Limerick BioPharma, Inc., a developer of innovative therapies that help cells pump out unwanted or toxic substances, will announce new results from human trials of its lead compound, LIM-0705, at the 23rd International Congress of the Transplantation Society in Vancouver, Canada, in an oral presentation on August 19, 2010.

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines.

FDA, EMA accept boceprevir for expedited review

Merck, known as MSD outside the United States and Canada, announced today that regulatory applications for boceprevir, Merck's investigational oral hepatitis C virus (HCV) protease inhibitor, were submitted in 2010 and have been accepted for expedited review in both the U.S. and the European Union.

Read more Medical News

› Verified 6 days ago